Samira Sakhia

Samira Sakhia is a member of the Board of Directors and a member of the Audit Committee. Ms. Sakhia joined Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company in August 2016 as President and a member of the board of directors. She was named President and Chief Operating Officer of Knight in June 2020. She served additionally as its Chief Financial Officer from October 2017 to March 2020. Prior to joining Knight, Ms. Sakhia served as the Chief Financial Officer at Paladin Labs Inc., a specialty pharmaceutical company from 2001 to 2015. At Paladin, Ms. Sakhia was responsible for the finance, operations, human resources and investor relations functions, and completed the sale of Paladin to Endo International. Ms. Sakhia serves on the board of the Montreal Society for the Prevention of Cruelty to Animals, the International Advisory Board of McGill’s Desautels Faculty of Management, and is a member of the Board of Governors of McGill University and an independent Board member at the McGill University Health Center. Ms. Sakhia holds an MBA, a Bachelor of Commerce and a Graduate Diploma in Accountancy from McGill University.